Perioperative Management of Asthma in Cesarean Section

download Perioperative Management of Asthma in Cesarean Section

of 29

Transcript of Perioperative Management of Asthma in Cesarean Section

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    1/29

    PERIOPERATIVEPERIOPERATIVE

    MANAGEMENT OFMANAGEMENT OF

    ASTHMAASTHMA ININCESAREANCESAREAN

    SECTIONSECTION

    Houman Teymourian, M.DHouman Teymourian, M.D..Assistant professor, Department ofAssistant professor, Department ofAnesthesiology and Critical Care,Anesthesiology and Critical Care,

    Shahid Beheshti MedicalShahid Beheshti MedicalUniversityUniversity

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    2/29

    ASTHMAASTHMA

    Asthma is a very common chronic diseaseAsthma is a very common chronic disease

    150 million people worldwide are affected150 million people worldwide are affected

    The most common respiratory disease inThe most common respiratory disease in

    women of childbearing agewomen of childbearing age 4% of all pregnancies are complicated by4% of all pregnancies are complicated by

    asthmaasthma

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    3/29

    DEFINITION &DEFINITION &

    PATHOPHYSIOLOGYPATHOPHYSIOLOGY It is a chronic inflammatory diseaseIt is a chronic inflammatory disease

    of the airways involving multipleof the airways involving multiplecomponents of immune systemcomponents of immune system (mast(mast

    cells, eosinophils,cells, eosinophils,neutrophils, T cell lymphocytesneutrophils, T cell lymphocytes& cysteinyl leukotrienes& cysteinyl leukotrienes))

    Is associated with :Is associated with : acuteacutebronchoconstriction , airway edema , mucus plugbronchoconstriction , airway edema , mucus plug

    formation ,& airway wall remodelingformation ,& airway wall remodeling Hyper reactivity ,Hypertrophy,Hyper reactivity ,Hypertrophy,

    Autonomic dysfunction, InflammationAutonomic dysfunction, Inflammation

    secretion & edemasecretion & edema

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    4/29

    CLASSIFICATIONCLASSIFICATION

    1.1. Childhood-onset asthma (extrinsic)Childhood-onset asthma (extrinsic)

    2.2. Adult-onset asthma (intrinsic)Adult-onset asthma (intrinsic)

    or traditionally:or traditionally: Mild , Moderate , SevereMild , Moderate , Severe Women with severe asthma tends toWomen with severe asthma tends to

    have more pronounced exacerbations ofhave more pronounced exacerbations ofdisease during pregnancydisease during pregnancy

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    5/29

    CLASSIFICATION OFCLASSIFICATION OF

    ASTHMA SEVERITYASTHMA SEVERITY

    STEP 1 (mild intermittent)STEP 1 (mild intermittent)Symptoms:Symptoms: 80% predicted

    STEP 2 (mild persistent)STEP 2 (mild persistent)Symptoms:Symptoms: >2 times a weak but2 times a weak but 2 times a month> 2 times a month

    Lung function:Lung function: FEV1 >80% predictedFEV1 >80% predicted

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    6/29

    STEP 3 (moderate persistent)STEP 3 (moderate persistent)Symptoms:Symptoms: daily , daily use of inhaled short actingdaily , daily use of inhaled short acting

    22 agonists, exacerbations affect activity andagonists, exacerbations affect activity and

    are >2 time a weak , may last daysare >2 time a weak , may last days

    Nighttime symptoms:Nighttime symptoms: > 1 time a weak> 1 time a weak

    Lung function:Lung function: FEV1 >60 -60 -

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    7/29

    PHYSIOLOGIC CHANGES OFPHYSIOLOGIC CHANGES OF

    PREGNANCYPREGNANCY

    Cardiovascular:Cardiovascular: HR, SV , CO ,BP ,SVR , PVRHR, SV , CO ,BP ,SVR , PVR Respiratory:Respiratory: MV , VT ,FRC , & RR remainsMV , VT ,FRC , & RR remains

    unchanged, CO2 production but PaCO2unchanged, CO2 production but PaCO2

    capillary engorgement of mucosa and edema ofcapillary engorgement of mucosa and edema ofthe oropharynx ,larynx ,and tracheathe oropharynx ,larynx ,and trachea

    Hematologic:Hematologic: Blood volume 45%, red cellBlood volume 45%, red cell30%30%

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    8/29

    EFFECTS OF ASTHMA ONEFFECTS OF ASTHMA ON

    PREGNANCYPREGNANCY The rate of prematurity ,pregnancyThe rate of prematurity ,pregnancy

    induced hypertension , perinatal mortalityinduced hypertension , perinatal mortality

    , low birth weight are increased, low birth weight are increased (particularly in(particularly in

    steroid dependents)steroid dependents) Pre & post partum hemorrhage, pretermPre & post partum hemorrhage, preterm

    labor , premature rupture of membraneslabor , premature rupture of membranes

    Neonatal tachycardia & transientNeonatal tachycardia & transient

    tachypneatachypnea Increase in need to induce labor & theIncrease in need to induce labor & the

    rate of cesarean sectionrate of cesarean section

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    9/29

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    10/29

    TREATMENT OF ASTHMATREATMENT OF ASTHMA

    Removal of triggers , monitoring ,patientRemoval of triggers , monitoring ,patient

    educationeducation

    STEP 1 (mild intermittent):STEP 1 (mild intermittent):

    Inhaled short actingInhaled short acting2-2-agonist ( e.g. albuterol )agonist ( e.g. albuterol )

    STEP 2 (mild persistent):STEP 2 (mild persistent):

    step 1 +anti inflammatory (Inhaled steroid or cromolyn sodium) +step 1 +anti inflammatory (Inhaled steroid or cromolyn sodium) +possible use of sustained-release theophyllinepossible use of sustained-release theophylline

    STEP 3 ( moderate persistent):STEP 3 ( moderate persistent):long actinglong acting 2-2-agonistagonist (e.g. salmeterol) + Inhaled steroid(e.g. salmeterol) + Inhaled steroid

    STEP 4 (severe persistent):STEP 4 (severe persistent):all above + systemic steroidall above + systemic steroid

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    11/29

    TREATMENT OF ASTHMATREATMENT OF ASTHMA

    DURING PREGNANCYDURING PREGNANCY

    Poor treatment of asthma duringPoor treatment of asthma during

    pregnancy contribute significantly topregnancy contribute significantly to

    adverse outcomeadverse outcome

    The risk of untreated asthma farThe risk of untreated asthma far

    exceeds the risk of the medicationsexceeds the risk of the medications

    Use ofUse of2-2-agonistsagonists is safe.is safe.

    Use of oral corticosteroids isUse of oral corticosteroids is

    associated with pregnancy-inducedassociated with pregnancy-induced

    hypertension & weakly with low-birthhypertension & weakly with low-birth

    weight & cleft palateweight & cleft palate

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    12/29

    Anti cholinergics (Ipratropium) mayAnti cholinergics (Ipratropium) may

    be useful.be useful.

    During delivery ,During delivery , InhaledInhaled

    2-2-agonists +agonists +

    steroidsteroid++ supplemental Osupplemental O22 should beshould beused forused for anyany level of asthmalevel of asthma

    Leukotriene modifiers are safe duringLeukotriene modifiers are safe during

    pregnancy (zafirlukast ,montelukast)pregnancy (zafirlukast ,montelukast)

    Zileuton is associated with IUGR,Zileuton is associated with IUGR,

    cleft palate, & long bonecleft palate, & long bone

    abnormalitiesabnormalities

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    13/29

    Status AsmathicusStatus Asmathicus

    Severe bronchospasm unresponsiveSevere bronchospasm unresponsive

    to systemic steroids &to systemic steroids & 2-2-agonists thatagonists thatrequires mechanical ventilation & sedationrequires mechanical ventilation & sedation

    & may be muscle relaxants & volatile& may be muscle relaxants & volatileanestheticsanesthetics

    Use permissive hypercarbia ,Use permissive hypercarbia ,

    anticholinergics , heliox , methyl xantinesanticholinergics , heliox , methyl xantines

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    14/29

    STATUS ASTHMATICUS INSTATUS ASTHMATICUS IN

    PREGNANTSPREGNANTS In pregnants permissive hypercarbiaIn pregnants permissive hypercarbia

    cannot be achievedcannot be achieved

    PPV may make the decrease in cardiac outPPV may make the decrease in cardiac out

    put even more pronouncedput even more pronounced Position is important( aortocavalPosition is important( aortocaval

    compression )compression )

    2-2-agonists & theophylline can causeagonists & theophylline can causeexcessive tachycardia in mother & atrialexcessive tachycardia in mother & atrial

    arrhythmia in fetusarrhythmia in fetus

    Heliox : only if adequate oxygenation canHeliox : only if adequate oxygenation can

    be achieved with an FIO2 less than 0.4be achieved with an FIO2 less than 0.4

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    15/29

    Magnesium sulfate particularly inMagnesium sulfate particularly in

    pregnancy-induced hypertension andpregnancy-induced hypertension and

    asthmaasthma

    There is some evidence that epiduralThere is some evidence that epiduralanesthesia alone can be efficacious inanesthesia alone can be efficacious in

    termination of status asthmaticus in thetermination of status asthmaticus in the

    parturientparturient

    Early termination of pregnancy may beEarly termination of pregnancy may be

    necessary to insure the survival of thenecessary to insure the survival of the

    mother and may result in immediatemother and may result in immediate

    improvement in the respiratory statusimprovement in the respiratory status

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    16/29

    ANESTHESIA FOR LABORANESTHESIA FOR LABOR

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    17/29

    ANESTHESIA FOR LABORANESTHESIA FOR LABOR

    AND CESAREAN SECTION INAND CESAREAN SECTION IN

    THE ASMATHIC PATIENTTHE ASMATHIC PATIENT Basic principles:Basic principles:

    1.1. Optimization of pulmonary statusOptimization of pulmonary status

    before anesthesiabefore anesthesia

    2.2. Avoidance of bronchospasm inducingAvoidance of bronchospasm inducing

    agents (histamine releasers)agents (histamine releasers)

    3.3. Avoidance of airway irritation by anAvoidance of airway irritation by anendotracheal tube whenever possibleendotracheal tube whenever possible

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    18/29

    Neuraxial Anesthesia ForNeuraxial Anesthesia For

    Cesarean SectionCesarean Section Epidural , Spinal , Combined spinal-Epidural , Spinal , Combined spinal-

    epiduralepidural

    Epidural anesthesia decreasesEpidural anesthesia decreases

    catecholamine levels & Ocatecholamine levels & O22consumption , and may result inconsumption , and may result in

    termination of the status asthmaticustermination of the status asthmaticus

    Few cases of bronchospasm hasFew cases of bronchospasm has

    been reported after spinal anesthesiabeen reported after spinal anesthesia

    Patients on steroid therapy may bePatients on steroid therapy may be

    at risk for infectionsat risk for infections

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    19/29

    No special considerations regardingNo special considerations regardingchoice of local anesthetics for thischoice of local anesthetics for thispopulationpopulation

    Careful attention must be paid toCareful attention must be paid toavoidance of high block & respiratoryavoidance of high block & respiratoryfailurefailure

    Maintenance of AdequateMaintenance of Adequateintravascular volume is importantintravascular volume is important If opioids are used either epidural orIf opioids are used either epidural or

    intrathecally the patient must beintrathecally the patient must be

    monitored carefully for respiratorymonitored carefully for respiratory

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    20/29

    GENERAL ANESTHESIAGENERAL ANESTHESIA

    General anesthesia only if neuraxialGeneral anesthesia only if neuraxial

    anesthesia is contraindicatedanesthesia is contraindicated

    Risk of bronchospasm is high:Risk of bronchospasm is high:1.1. Tracheal intubationTracheal intubation

    2.2. Rapid sequence inductionRapid sequence induction

    3.3. Anesthetic level InsufficiencyAnesthetic level Insufficiency

    Agents for induction: mostAgents for induction: mostcommonly thiopental, ketamin ,commonly thiopental, ketamin ,

    propofolpropofol

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    21/29

    Ketamin : has mild bronchodilatoryKetamin : has mild bronchodilatoryaction due to release of endogenousaction due to release of endogenouscatecholaminescatecholamines

    Propofol: efficacious in bluntingPropofol: efficacious in bluntingairway responces & has weakairway responces & has weakbronchodilatory action butbronchodilatory action buthemodynamic changes must behemodynamic changes must bemanaged appropriately andmanaged appropriately andaggressively in parturientaggressively in parturient

    Thiopental: can cause histamineThiopental: can cause histamine

    release, doses which is safe for fetusrelease, doses which is safe for fetus

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    22/29

    Lidocaine: is useful as an adjuvant toLidocaine: is useful as an adjuvant to

    thiopental induction (1 mg/kg isthiopental induction (1 mg/kg is

    enough to attenuate both airway andenough to attenuate both airway and

    hemodynamic responses) ,hemodynamic responses) ,Aerosolized lidocaine is airwayAerosolized lidocaine is airway

    irritant and should not be usedirritant and should not be used

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    23/29

    MUSCLE RELAXANTSMUSCLE RELAXANTS

    Succinylcholine can be used forSuccinylcholine can be used for

    initial relaxationinitial relaxation

    Rocuronium is a safe alternativeRocuronium is a safe alternativein asthmaticsin asthmatics

    Atracurium & Rapacuronium canAtracurium & Rapacuronium can

    worsen bronchospasm &worsen bronchospasm &histamine releasehistamine release

    Cisatracurium also is a choiceCisatracurium also is a choice

    REVERSAL OFREVERSAL OF

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    24/29

    REVERSAL OFREVERSAL OF

    NEUROMUSCULARNEUROMUSCULAR

    BLOCKADEBLOCKADE Neostigmine can exacerbate airflowNeostigmine can exacerbate airflowobstruction by increasing secretionsobstruction by increasing secretions

    and bronchospasmand bronchospasm

    Edrophonium is a better choice inEdrophonium is a better choice in

    asthmatic patientsasthmatic patients

    Use of atropine or glycopyrrolate canUse of atropine or glycopyrrolate can

    attenuate these effectsattenuate these effects

    Succinylcholine infusion may beSuccinylcholine infusion may be

    used to avoid using reversal agentsused to avoid using reversal agents

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    25/29

    Maintenance ofMaintenance of

    anesthesiaanesthesia Halogenated agents haveHalogenated agents have

    bronchodialating properties :bronchodialating properties :

    halothane, isoflurane , sevofluranehalothane, isoflurane , sevoflurane

    Disadvantage: using high alveolarDisadvantage: using high alveolar

    concentration (>1 1.5 MAC) forconcentration (>1 1.5 MAC) for

    control of bronchospasm increasecontrol of bronchospasm increase

    bleeding from uterine relaxationbleeding from uterine relaxation Halothane disadvantage : cardiacHalothane disadvantage : cardiac

    irritability particularly in highirritability particularly in high

    catecholamine state andcatecholamine state and

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    26/29

    Extubation take place when theExtubation take place when the

    patient is fully awake & airwaypatient is fully awake & airway

    obstruction controlledobstruction controlled

    Patient should be treated duringPatient should be treated during

    surgery with Steroids &surgery with Steroids & 2-agonist2-agonist

    Lidocaine infusion decreases airwayLidocaine infusion decreases airwayreactivity during emergencereactivity during emergence

    Post operative Mechanical ventilationPost operative Mechanical ventilation

    may be necessary to controlmay be necessary to control

    obstructionobstruction

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    27/29

    Postpartum HemorrhagePostpartum Hemorrhage

    Is Increased in asthmatics due to:Is Increased in asthmatics due to: Abnormalities in smooth muscles andAbnormalities in smooth muscles and

    neural regulation of contractionneural regulation of contraction

    Peripartum use ofPeripartum use of2-agonists2-agonists Use of Oxytocin is valid inUse of Oxytocin is valid in

    asthmaticsasthmatics

    Use of Ergot alkaloid e.g.Use of Ergot alkaloid e.g.methylegonovinemethylegonovine

    ( methergine) & ergonovine( methergine) & ergonovine

    (ergotrate) is relatively(ergotrate) is relatively

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    28/29

    Postpartum HemorrhagePostpartum Hemorrhage

    Prostaglandins used for uterineProstaglandins used for uterine

    atony :atony : E causes bronchodilatationE causes bronchodilatation

    (only vaginal gel is available)(only vaginal gel is available) F2F2 causes bronchoconstrictioncauses bronchoconstriction

    Severe bronchospasm might beSevere bronchospasm might bepreferable to cardiovascularpreferable to cardiovascular

    collapsecollapse

  • 8/14/2019 Perioperative Management of Asthma in Cesarean Section

    29/29